Publication:
Hyperbaric Oxygen Therapy : A new Evolving Future Perspective for Management of Mucormycosis and COVID 19 in Children in Developing Countries

Simple item page
creativeworkseries.issnISSN 1990-7974 eISSN 1990-7982
dc.contributor.authorLakra, Mahaveer
dc.contributor.authorTaksande, Amar
dc.contributor.authorLakhkar, Bhavana
dc.contributor.authorDamke, Sachin
dc.contributor.authorLakra, Ashwini
dc.date.accessioned2025-11-12T08:29:45Z
dc.date.available2025-11-12T08:29:45Z
dc.date.issued2022
dc.descriptionMahaveer Lakra Department of Paediatrics, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (DMIMS), Sawangi Meghe, Wardha, Maharashtra, India Amar Taksande Department of Paediatrics, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (DMIMS), Sawangi Meghe, Wardha, Maharashtra, India Bhavana Lakhkar Department of Neonatology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (DMIMS), Sawangi Meghe, Wardha, Maharashtra, India Sachin Damke Department of Paediatrics, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (DMIMS), Sawangi Meghe, Wardha, Maharashtra, India Ashwini Lakra Senior Resident, Datta Meghe Medical College and SMHRC, Wanadongri, Nagpur, Maharashtra, India
dc.description.abstractAbstract: The SARS COVID-19 virus has arisen as a major hazard to mankind, posing harm to the whole world population. During the second COVID wave, mucormycosis has emerged as one of the deadliest and most devastating illnesses. Mucormycosis is strongly associated with diabetes, prolonged use of steroids, prolonged hospitalisation and immunocompromised states. Children have also been affected by this badly. Hyperbaric oxygen therapy is a non-invasive, cost-effective and painless therapy where 100% oxygen is given to patients under high atmospheric pressure in small tents or chambers. It helps in tissue regeneration and angiogenesis. Hyperbaric oxygen has proved to be effective in the treatment of oculo-rhino-cerebral mucormycosis. Various studies have proved its role in the management of mucormycosis and acute respiratory distress syndrome associated with COVID-19 infection. The advantages of hyperbaric oxygen are same in children as in adults with minimum side effects. Hyperbaric oxygen therapy can be one of the good adjunctive therapies in the management of mucormycosis. It is found to be safe in the treatment of COVID-19 infection, but data is still limited on its use and further studies are needed. This article is all about its use, its efficacy, and future perspectives in the management of mucormycosis and COVID-19 in view of the arrival of the third COVID wave in developing countries like India.
dc.identifierhttps://doi.org/10.3126/jnps.v42i1.42443
dc.identifier.urihttps://hdl.handle.net/20.500.14572/3145
dc.language.isoen_US
dc.publisherNepal Paediatric Society (JNPS)
dc.subjectCOVID 19
dc.subjectHyperbaric oxygen
dc.subjectMucormycosis
dc.subjectOxygen tank
dc.subjectTissue hypoxia
dc.titleHyperbaric Oxygen Therapy : A new Evolving Future Perspective for Management of Mucormycosis and COVID 19 in Children in Developing Countries
dc.typeArticle
dspace.entity.typePublication
local.article.typeReview Article
oaire.citation.endPage7
oaire.citation.startPage1
relation.isJournalIssueOfPublication27242f0c-36e4-409b-b4d9-92c2b98ff87a
relation.isJournalIssueOfPublication.latestForDiscovery27242f0c-36e4-409b-b4d9-92c2b98ff87a
relation.isJournalOfPublication6f9be05c-05a9-4a3e-a5b5-a19a15ab042c

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
1-7.pdf
Size:
274.97 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Publications

Connect with us

Nepal Health Research Council © 2023
Ramshah Path, Kathmandu Nepal P.O.Box 7626